MAINTENANCE OF ENDOMETRIOSIS-ASSOCIATED PAIN REDUCTION AND QUALITY OF LIFE IMPROVEMENT IN PHASE 3 EXTENSION STUDIES WITH ELAGOLIX.

被引：2
|
作者：
Taylor, H. S. [1 ]
Johnson, N. [2 ]
Carr, B. [3 ]
Leyland, N. [4 ]
Rechberger, T. [5 ]
Duan, W. R. [6 ]
Peloso, P. M. [6 ]
Soliman, A. M. [6 ]
Schwefel, B. [6 ]
Chwalisz, K. [6 ]
机构：
[1] Yale Sch Med, New Haven, CT USA
[2] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia
[3] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[4] McMaster Univ, Hamilton, ON, Canada
[5] Med Univ Lublin, Lublin, Poland
[6] AbbVie, N Chicago, IL USA
来源：
FERTILITY AND STERILITY | 2017年 / 108卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2017.07.294
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O-234
引用
收藏
页码：E96 / E97
页数：2
相关论文
共 50 条
  • [31] Relugolix Combination Therapy Minimizes Bone Loss in Patients with Endometriosis-associated Pain: Results from the Phase 3 SPIRIT Program
    McClung, Michael R.
    Santora, Arthur
    Johnson, Neil
    Cummings, Steve R.
    Imm, So-Jung
    Wagman, Rachel B.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 109 - 109
  • [32] Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3)
    Donnez, Jacques
    Becker, Christian
    Taylor, Hugh
    Carmona Herrera, Francisco
    Donnez, Olivier
    Horne, Andrew
    Paszkowski, Maciej
    Petraglia, Felice
    Renner, Stefan P.
    Patel, Amisha
    Boolell, Mitra
    Bestel, Elke
    Dolmans, Marie-Madeleine
    HUMAN REPRODUCTION, 2024, 39 (06) : 1208 - 1221
  • [33] ELAGOLIX, AN ORAL GONADOTROPIN-RELEASING HORMONE ANTAGONIST, FOR THE MANAGEMENT OF ENDOMETRIOSIS-ASSOCIATED PAIN: SAFETY AND EFFICACY RESULTS FROM TWO DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDIES.
    Taylor, H. S.
    Giudice, L. C.
    Lesley, B. A.
    Abrao, M.
    Kotarski, J.
    Williams, L. A.
    Rowan, J. P.
    Chwalisz, K.
    Duan, W. R.
    Schwefel, B.
    Thomas, J. W.
    Jain, R. I.
    FERTILITY AND STERILITY, 2016, 106 (03) : E271 - E271
  • [34] Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: A double-blind, randomized, placebo-controlled trial
    Miller, JD
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 182 (06) : 1483 - 1487
  • [35] LINZAGOLIX FOR ENDOMETRIOSIS-ASSOCIATED PAIN: SAFETY RESULTS FROM EDELWEISS 3, A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Donnez, J.
    Taylor, H.
    Gemzell-Danielsson, K.
    Catherino, W.
    Bestel, E.
    Gotteland, J. P.
    Humberstone, A.
    Moore, L.
    Garner, E.
    HUMAN REPRODUCTION, 2022, 37 : I111 - I111
  • [36] Efficacy results from a phase 3, randomized, placebo-controlled trial testing two doses of linzagolix in women with endometriosis-associated pain
    Dolmans, M. M.
    Becker, C. M.
    Petraglia, F.
    Donnez, J.
    Boolell, M.
    Bestel, E.
    HUMAN REPRODUCTION, 2023, 38
  • [37] Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: A double-blind, randomized, placebo-controlled trial - Discussion
    Keye, WR
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 182 (06) : 1487 - 1488
  • [38] Quality of Life in Japanese Patients with Dysmenorrhea or Endometriosis-Associated Pelvic Pain Treated with Extended Regimen Ethinylestradiol/Drospirenone in a Real-World Setting: A Prospective Observational Study
    Yoshino, Osamu
    Suzukamo, Yoshimi
    Yoshihara, Keisuke
    Takahashi, Noriko
    ADVANCES IN THERAPY, 2022, 39 (11) : 5087 - 5104
  • [39] Quality of Life in Japanese Patients with Dysmenorrhea or Endometriosis-Associated Pelvic Pain Treated with Extended Regimen Ethinylestradiol/Drospirenone in a Real-World Setting: A Prospective Observational Study
    Osamu Yoshino
    Yoshimi Suzukamo
    Keisuke Yoshihara
    Noriko Takahashi
    Advances in Therapy, 2022, 39 : 5087 - 5104
  • [40] Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2)
    Giudice, Linda C.
    As-Sanie, Sawsan
    Ferreira, Juan C. Arjona
    Becker, Christian M.
    Abrao, Mauricio S.
    Lessey, Bruce A.
    Brown, Eric
    Dynowski, Krzysztof
    Wilk, Krzysztof
    Li, Yulan
    Mathur, Vandana
    Warsi, Qurratul Ann
    Wagman, Rachel B.
    Johnson, Neil P.
    LANCET, 2022, 399 (10343): : 2267 - 2279
12345